Cargando…
Tumor-Associated Macrophages in Hepatocellular Carcinoma Pathogenesis, Prognosis and Therapy
SIMPLE SUMMARY: Hepatocellular carcinoma (HCC) constitutes a major health burden, accounting for >80% of primary liver cancers globally. Inflammation has come into the spotlight as a hallmark of cancer, and it is evident that tumor-associated inflammation drives the involvement of monocytes in tu...
Autores principales: | Arvanitakis, Konstantinos, Koletsa, Triantafyllia, Mitroulis, Ioannis, Germanidis, Georgios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749970/ https://www.ncbi.nlm.nih.gov/pubmed/35008390 http://dx.doi.org/10.3390/cancers14010226 |
Ejemplares similares
-
Tumor-Associated Neutrophils in Hepatocellular Carcinoma Pathogenesis, Prognosis, and Therapy
por: Arvanitakis, Konstantinos, et al.
Publicado: (2021) -
The Liver Cancer Immune Microenvironment: Emerging Concepts for Myeloid Cell Profiling with Diagnostic and Therapeutic Implications
por: Arvanitakis, Konstantinos, et al.
Publicado: (2023) -
Unveiling the Yin-Yang Balance of M1 and M2 Macrophages in Hepatocellular Carcinoma: Role of Exosomes in Tumor Microenvironment and Immune Modulation
por: Papadakos, Stavros P., et al.
Publicado: (2023) -
How Far beyond Diabetes Can the Benefits of Glucagon-like Peptide-1 Receptor Agonists Go? A Review of the Evidence on Their Effects on Hepatocellular Carcinoma
por: Arvanitakis, Konstantinos, et al.
Publicado: (2022) -
Interplay of Extracellular Vesicles and TLR4 Signaling in Hepatocellular Carcinoma Pathophysiology and Therapeutics
por: Papadakos, Stavros P., et al.
Publicado: (2023)